Sitagliptin "Laurus" 100 mg filmovertrukne tabletter Դանիա - դանիերեն - Lægemiddelstyrelsen (Danish Medicines Agency)

sitagliptin "laurus" 100 mg filmovertrukne tabletter

laurus generics gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 100 mg

Sitagliptin "Laurus" 50 mg filmovertrukne tabletter Դանիա - դանիերեն - Lægemiddelstyrelsen (Danish Medicines Agency)

sitagliptin "laurus" 50 mg filmovertrukne tabletter

laurus generics gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 50 mg

Sitagliptin "Reddy" 100 mg filmovertrukne tabletter Դանիա - դանիերեն - Lægemiddelstyrelsen (Danish Medicines Agency)

sitagliptin "reddy" 100 mg filmovertrukne tabletter

reddy holding gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 100 mg

Sitagliptin "Reddy" 50 mg filmovertrukne tabletter Դանիա - դանիերեն - Lægemiddelstyrelsen (Danish Medicines Agency)

sitagliptin "reddy" 50 mg filmovertrukne tabletter

reddy holding gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 50 mg

Galvus Եվրոպական Միություն - դանիերեն - EMA (European Medicines Agency)

galvus

novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - narkotika anvendt i diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Jalra Եվրոպական Միություն - դանիերեն - EMA (European Medicines Agency)

jalra

novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).

Xiliarx Եվրոպական Միություն - դանիերեն - EMA (European Medicines Agency)

xiliarx

novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - narkotika anvendt i diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).